Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Cited In for PubMed (Select 10694577)

1.

Role of Apolipoprotein E in β-Amyloidogenesis: ISOFORM-SPECIFIC EFFECTS ON PROTOFIBRIL TO FIBRIL CONVERSION OF Aβ IN VITRO AND BRAIN Aβ DEPOSITION IN VIVO.

Hori Y, Hashimoto T, Nomoto H, Hyman BT, Iwatsubo T.

J Biol Chem. 2015 Jun 12;290(24):15163-74. doi: 10.1074/jbc.M114.622209. Epub 2015 Apr 27.

PMID:
25918154
2.

APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.

Liu DS, Pan XD, Zhang J, Shen H, Collins NC, Cole AM, Koster KP, Ben Aissa M, Dai XM, Zhou M, Tai LM, Zhu YG, LaDu M, Chen XC.

Mol Neurodegener. 2015 Mar 5;10:7. doi: 10.1186/s13024-015-0002-2.

3.
4.

Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives.

Tong LM, Fong H, Huang Y.

Exp Mol Med. 2015 Mar 13;47:e151. doi: 10.1038/emm.2014.124. Review.

5.

IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior.

Chakrabarty P, Li A, Ceballos-Diaz C, Eddy JA, Funk CC, Moore B, DiNunno N, Rosario AM, Cruz PE, Verbeeck C, Sacino A, Nix S, Janus C, Price ND, Das P, Golde TE.

Neuron. 2015 Feb 4;85(3):519-33. doi: 10.1016/j.neuron.2014.11.020. Epub 2015 Jan 22.

PMID:
25619653
6.

APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?

Brickman AM, Schupf N, Manly JJ, Stern Y, Luchsinger JA, Provenzano FA, Narkhede A, Razlighi Q, Collins-Praino L, Artero S, Akbaraly TN, Ritchie K, Mayeux R, Portet F.

Alzheimers Dement. 2014 Nov;10(6):619-29. doi: 10.1016/j.jalz.2014.07.155. Epub 2014 Oct 7.

PMID:
25304991
7.

Insulin resistance in Alzheimer's disease.

Dineley KT, Jahrling JB, Denner L.

Neurobiol Dis. 2014 Dec;72 Pt A:92-103. doi: 10.1016/j.nbd.2014.09.001. Epub 2014 Sep 16.

PMID:
25237037
8.

Molecular Differences and Similarities Between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis.

Maarouf CL, Kokjohn TA, Whiteside CM, Macias MP, Kalback WM, Sabbagh MN, Beach TG, Vassar R, Roher AE.

Biochem Insights. 2013 Nov 21;6:1-10. doi: 10.4137/BCI.S13025. eCollection 2013.

9.

The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation.

Garai K, Verghese PB, Baban B, Holtzman DM, Frieden C.

Biochemistry. 2014 Oct 14;53(40):6323-31. doi: 10.1021/bi5008172. Epub 2014 Sep 25.

PMID:
25207746
10.

Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.

Huang Y, Mahley RW.

Neurobiol Dis. 2014 Dec;72 Pt A:3-12. doi: 10.1016/j.nbd.2014.08.025. Epub 2014 Aug 27.

PMID:
25173806
11.

Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance.

Marr RA, Hafez DM.

Front Aging Neurosci. 2014 Aug 13;6:187. doi: 10.3389/fnagi.2014.00187. eCollection 2014. Review.

12.

Towards understanding the roles of heparan sulfate proteoglycans in Alzheimer's disease.

Zhang GL, Zhang X, Wang XM, Li JP.

Biomed Res Int. 2014;2014:516028. doi: 10.1155/2014/516028. Epub 2014 Jul 23.

13.

Can education rescue genetic liability for cognitive decline?

Cook CJ, Fletcher JM.

Soc Sci Med. 2015 Feb;127:159-70. doi: 10.1016/j.socscimed.2014.06.049. Epub 2014 Jul 7.

PMID:
25074513
14.

Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.

Bachmeier C, Shackleton B, Ojo J, Paris D, Mullan M, Crawford F.

Neuromolecular Med. 2014 Dec;16(4):686-96.

PMID:
25015123
15.

Alzheimer's disease genetics: from the bench to the clinic.

Karch CM, Cruchaga C, Goate AM.

Neuron. 2014 Jul 2;83(1):11-26. doi: 10.1016/j.neuron.2014.05.041. Review.

16.

Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice.

Pankiewicz JE, Guridi M, Kim J, Asuni AA, Sanchez S, Sullivan PM, Holtzman DM, Sadowski MJ.

Acta Neuropathol Commun. 2014 Jun 28;2:75. doi: 10.1186/s40478-014-0075-0.

17.

Alzheimer's disease risk genes and mechanisms of disease pathogenesis.

Karch CM, Goate AM.

Biol Psychiatry. 2015 Jan 1;77(1):43-51. doi: 10.1016/j.biopsych.2014.05.006. Epub 2014 May 17.

PMID:
24951455
18.

LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice.

Stukas S, Freeman L, Lee M, Wilkinson A, Ossoli A, Vaisman B, Demosky S, Chan J, Hirsch-Reinshagen V, Remaley AT, Wellington CL.

J Lipid Res. 2014 Jun 20;55(8):1721-1729. [Epub ahead of print]

19.

HSV-1 and Alzheimer's disease: more than a hypothesis.

Piacentini R, De Chiara G, Li Puma DD, Ripoli C, Marcocci ME, Garaci E, Palamara AT, Grassi C.

Front Pharmacol. 2014 May 7;5:97. doi: 10.3389/fphar.2014.00097. eCollection 2014. Review.

20.

Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer's disease?

Luque-Contreras D, Carvajal K, Toral-Rios D, Franco-Bocanegra D, Campos-Peña V.

Oxid Med Cell Longev. 2014;2014:497802. doi: 10.1155/2014/497802. Epub 2014 Jan 20. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk